{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:22:02Z","timestamp":1761895322503},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T00:00:00Z","timestamp":1311206400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11255-011-0030-y","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T10:25:10Z","timestamp":1311157510000},"page":"335-341","source":"Crossref","is-referenced-by-count":11,"title":["The effects of long-term medical treatment combined with clean intermittent catheterization in children with neurogenic detrusor overactivity"],"prefix":"10.1007","volume":"44","author":[{"given":"Thomas","family":"Lehnert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Till","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Rolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,21]]},"reference":[{"key":"30_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1464-410X.92.s1.2.x","volume":"92","author":"SB Bauer","year":"2003","unstructured":"Bauer SB (2003) The management of myelodysplastic child: a paradigm shift. BJU Int 92:23\u201328","journal-title":"BJU Int"},{"key":"30_CR2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2005.12.056","volume":"49","author":"P Dik","year":"2006","unstructured":"Dik P, Klijn AJ, van Gool JD, van Steenwijk CC, de Jong TP (2006) Early start to therapy preserves kidney function in spina bifida patients. Eur Urol 49:908\u2013913","journal-title":"Eur Urol"},{"key":"30_CR3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.sc.3101584","volume":"42","author":"A Reitz","year":"2004","unstructured":"Reitz A, Schurch B (2004) Intravesical therapy options for neurogenic detrusor overactivity. Spinal Cord 42:267\u2013272","journal-title":"Spinal Cord"},{"issue":"6","key":"30_CR4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00042307-200211000-00005","volume":"12","author":"AR Aslan","year":"2002","unstructured":"Aslan AR, Kogan BA (2002) Conservative management in neurogenic bladder dysfunction. Curr Opin Urol 12(6):473\u2013477","journal-title":"Curr Opin Urol"},{"issue":"4","key":"30_CR5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ucl.2006.06.011","volume":"33","author":"H Masuda","year":"2006","unstructured":"Masuda H, Kim YT, Tyagi S, Chancellor MB, de Miguel F, Yoshimura N (2006) Local effect of antimuscarinics. Urol Clin North Am 33(4):511\u2013518","journal-title":"Urol Clin North Am"},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00467-007-0691-z","volume":"23","author":"C Verpoorten","year":"2008","unstructured":"Verpoorten C, Buyse GM (2008) The neurogenic bladder: medical treatment. Pediatr Nephrol 23:717\u2013725","journal-title":"Pediatr Nephrol"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/nau.20370","volume":"26","author":"T Nev\u00e8us","year":"2007","unstructured":"Nev\u00e8us T, von Gontard A, Hoebecke P, Hj\u00e4lmas K, Bauer S, Bower W, Jorgensen TM, Rittig S, Walle JV, Yeung CK, Djurhuus JC (2007) The standardization of terminology of lower urinary tract function in children and adolescents: report from standardization committee of the international children\u2019s continence society (ICCS). Neurourol Urodyn 26:90\u2013102","journal-title":"Neurourol Urodyn"},{"issue":"3Pt2","key":"30_CR8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00005392-199709000-00156","volume":"158","author":"LS Palmer","year":"1997","unstructured":"Palmer LS, Richards I, Kaplan W (1997) Age related bladder capacity and bladder capacity growth in children with myelomeningocele. J Urol 158(3Pt2):1261\u20131264","journal-title":"J Urol"},{"key":"30_CR9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00467-008-0764-7","volume":"23","author":"SB Bauer","year":"2008","unstructured":"Bauer SB (2008) Neurogenic bladder: etiology and assessment. Pediatr Nephrol 23:541\u2013551","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"30_CR10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2008.01.007","volume":"53","author":"B Amend","year":"2008","unstructured":"Amend B, Hennenlotter J, Sch\u00e4fer T, Horstmann M, Stenzl A, Sievert KD (2008) Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side effects. Eur Urol 53(5):1021\u20131028","journal-title":"Eur Urol"},{"issue":"7","key":"30_CR11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1248\/bpb.30.1297","volume":"30","author":"R Takayanagi","year":"2007","unstructured":"Takayanagi R, Mizushima H, Ozeki T, Yokoyama H, Iga T, Yamada Y (2007) Analysis of pharmacological Effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects. Biol Pharm Bull 30(7):1297\u20131300","journal-title":"Biol Pharm Bull"},{"issue":"11","key":"30_CR12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00228-008-0528-0","volume":"64","author":"K May","year":"2008","unstructured":"May K, Giessmann T, Wegner D, Oertel R, Modess C, Oswald S, Braeter M, Siegmund W (2008) Oral absorption of propiverine solution and of the immediate and extended release dosage forms; influence of regioselective intestinal elimination. Eur J Clin Pharmacol 64(11):1085\u20131092","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"30_CR13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1464-410X.2008.08093.x","volume":"103","author":"H Madersbacher","year":"2009","unstructured":"Madersbacher H, M\u00fcrtz G, Alloussi S, Domurath B, Henne T, K\u00f6rner I, Niedeggen A, Nounla J, Pannek J, Schulte-Baukloh H, Schultz-Lampel D, Bock P, Strugala G (2009) Propiverine versus oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational study. BJU Int 103(6):776\u2013781","journal-title":"BJU Int"},{"issue":"1","key":"30_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.eururo.2006.03.016","volume":"51","author":"M St\u00f6hrer","year":"2007","unstructured":"St\u00f6hrer M, M\u00fcrtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele JJ (2007) Propiverine compared to oxybutynin in neurogenic detrusor overactivity\u2014results of a randomized, double-blind, multicenter clinical study. Eur Urol 51(1):235\u2013242","journal-title":"Eur Urol"},{"key":"30_CR15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(17)36663-6","volume":"148","author":"CA Massad","year":"1992","unstructured":"Massad CA, Kogan BA, Trigo-Rocha FE (1992) The pharmacokinetics of intravesical and oral oxybutinin chloride. J Urol 148:595\u2013597","journal-title":"J Urol"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1066260","volume":"Suppl 1","author":"G Buyse","year":"1995","unstructured":"Buyse G, Verpoorten C, Vereecken R, Casaer P (1995) Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy. Eur J Paed Surg Suppl 1:31\u201334","journal-title":"Eur J Paed Surg"},{"issue":"1","key":"30_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/003655902317259319","volume":"36","author":"K Lehtoranta","year":"2002","unstructured":"Lehtoranta K, Tainio H, Lukkari-Lax E, Hakonen T, Tammela TL (2002) Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity. Scand J Urol Nephrol 36(1):18\u201324","journal-title":"Scand J Urol Nephrol"},{"issue":"6","key":"30_CR18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1464-410X.1998.00888.x","volume":"82","author":"P Amark","year":"1998","unstructured":"Amark P, Eksborg S, Juneskans O, Bussman G, Palm C (1998) Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder. Br J Urol 82(6):859\u2013864","journal-title":"Br J Urol"},{"issue":"7119","key":"30_CR19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bmj.315.7119.1363","volume":"315","author":"CA Donnellan","year":"1997","unstructured":"Donnellan CA et al (1997) Oxybutynin and cognitive dysfunction. BMJ 315(7119):1363\u20131364","journal-title":"BMJ"},{"issue":"7","key":"30_CR20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1464-410x.2001.02152.x","volume":"87","author":"P Ferrara","year":"2001","unstructured":"Ferrara P, D`Aleo CM, Tarquinin E, Salvatore S, Dalvaggio E (2001) Side-effect of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int 87(7):674\u2013678","journal-title":"BJU Int"},{"key":"30_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.sc.3100995","volume":"38","author":"A Haferkamp","year":"2000","unstructured":"Haferkamp A, Staehler G, Gerner HJ, D\u00f6rsam J (2000) Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord 38:250\u2013254","journal-title":"Spinal Cord"},{"key":"30_CR22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpurol.2007.05.007","volume":"3","author":"A Hayashi","year":"2007","unstructured":"Hayashi A, Saito M, Okada S, Hanada T, Watanabe T, Satoh K, Kanzaki S (2007) Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children. J Pediatr Urol 3:438\u2013442","journal-title":"J Pediatr Urol"},{"issue":"2","key":"30_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000019701","volume":"34","author":"P Amark","year":"1998","unstructured":"Amark P, Bussman G, Eksborg S (1998) Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children. Eur Urol 34(2):148\u2013153","journal-title":"Eur Urol"},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, St\u00f6hrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burgd\u00f6rfer H, G\u00f6cking K, Madersbacher H, Schumacher S, Richter R, von Tobel J, Schurch B (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510\u2013515","journal-title":"Eur Urol"},{"issue":"6","key":"30_CR25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpurol.2009.06.001","volume":"5","author":"C Do Ngoc Thanh","year":"2009","unstructured":"Do Ngoc Thanh C, Audry G, Forin V (2009) Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: a retrospective study of seven cases. J Pediatr Urol 5(6):430\u2013436","journal-title":"J Pediatr Urol"},{"issue":"3","key":"30_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpurol.2009.01.005","volume":"5","author":"X Gam\u00e9","year":"2009","unstructured":"Gam\u00e9 X, Mouracade P, Chartier-Kastler E, Viehweger E, Moog R, Amarenco G, Denys P, De Seze M, Haab F, Karsenty G, Kerdraon J, Perrouin-Verbe B, Ruffion A, Soler JM, Saussine C (2009) Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol 5(3):156\u2013164","journal-title":"J Pediatr Urol"},{"issue":"4","key":"30_CR27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","volume":"66","author":"H Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Knispel HH, Stolze T, Weiss C, Michael T, Miller K (2005) Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 66(4):865\u2013870 discussion 870","journal-title":"Urology"},{"issue":"7","key":"30_CR28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/nau.20044","volume":"23","author":"E Ab","year":"2004","unstructured":"Ab E, Dik P, Klijn AJ, van Gool JD, de Jong TP (2004) Detrusor overactivity in spina bifida: how long does it need to be treated? Neurourol Urodyn 23(7):685\u2013688","journal-title":"Neurourol Urodyn"},{"issue":"2 Pt 1","key":"30_CR29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","volume":"171","author":"M Riccabona","year":"2004","unstructured":"Riccabona M, Koen M, Schindler M, Beckers G, Pycha A, Lusuardi L, Bauer SB (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171(2 Pt 1):845\u2013848","journal-title":"J Urol"},{"issue":"2","key":"30_CR30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4321\/S0210-48062011000200006","volume":"35","author":"RM Romero","year":"2011","unstructured":"Romero RM, Rivas S, Parente A, Fanjul M, Angulo JM (2011) Injection of botulinum toxin (BTX-A) in children with bladder dysfunction due to detrusor overactivity. Actas Urol Esp 35(2):89\u201392","journal-title":"Actas Urol Esp"},{"issue":"1","key":"30_CR31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","volume":"55","author":"A Apostolidis","year":"2009","unstructured":"Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, Karsenty G, Schulte-Baukloh H, Schurch B, Wyndaele JJ (2009) European consensus panel. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 55(1):100\u2013119","journal-title":"Eur Urol"},{"issue":"4","key":"30_CR32","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.ju.0000117865.98229.e5","volume":"171","author":"C Moore","year":"2004","unstructured":"Moore C, Kogan BA, Parekl A (2004) Impact of urinary incontinence on self-concept in children with spina bifida. J Urol 171(4):1659\u20131662","journal-title":"J Urol"},{"issue":"3","key":"30_CR33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1469-8749.2004.tb00467.x","volume":"46","author":"M Borzyskowski","year":"2004","unstructured":"Borzyskowski M, Cox A, Edwards M, Owen A (2004) Neuropathic bladder and intermittent catheterization: social and psychological impact on families. Dev Med Child Neurol 46(3):160\u2013167","journal-title":"Dev Med Child Neurol"},{"key":"30_CR34","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1100\/tsw.2007.271","volume":"7","author":"J George","year":"2007","unstructured":"George J, Tharion G, Richar J, Macaden AS, Thomas R, Bhattacharji S (2007) The effectiveness of intravesical oxybutynin, propantheline and capsaicin in the management of neuropathic bladder following spinal cord injury. Sci World J 7:1683\u20131690","journal-title":"Sci World J"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-011-0030-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-011-0030-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-011-0030-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:35:45Z","timestamp":1560386145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-011-0030-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,21]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s11255-011-0030-y","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,21]]}}}